ID

40368

Beschrijving

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy; ODM derived from: https://clinicaltrials.gov/show/NCT01782222

Link

https://clinicaltrials.gov/show/NCT01782222

Trefwoorden

Versies (1)
  1. 14-04-20 14-04-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

14 april 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Idiopathic Parkinson's Disease NCT01782222

Engels

Eligibility Idiopathic Parkinson's Disease NCT01782222

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with early or advanced idiopathic parkinson's disease
Beschrijving

Parkinson Disease Early | Parkinson Disease Advanced

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C1279919
UMLS CUI [2,1]
C0030567
UMLS CUI [2,2]
C0205179
patients with advanced idiopathic parkinson's disease: intake of levodopa on a stable dose of at least 200 mg/day
Beschrijving

Parkinson Disease Advanced | Levodopa Dose Stable U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0023570
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [2,4]
C0456683
unsatisfactory control of parkinson's disease motor symptoms under current treatment
Beschrijving

Control Unsatisfactory Parkinson Disease | Motor symptoms Treating

Datatype

boolean

Alias
UMLS CUI [1,1]
C2587213
UMLS CUI [1,2]
C0439856
UMLS CUI [1,3]
C0030567
UMLS CUI [2,1]
C0426980
UMLS CUI [2,2]
C1522326
patients experiencing apathy associated with parkinson's disease
Beschrijving

Apathy Associated with Parkinson Disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0085632
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0030567
hoehn and yahr stage score of i to iv
Beschrijving

Hoehn and Yahr Stage

Datatype

boolean

Alias
UMLS CUI [1]
C3639483
mini-mental state examination score ≥ 25
Beschrijving

Mini-mental state examination

Datatype

boolean

Alias
UMLS CUI [1]
C0451306
if an antidepressant drug is taken, the dose must be stable
Beschrijving

Antidepressive Agents Dose Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003289
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
therapy with a dopamine agonist
Beschrijving

Dopamine Agonists

Datatype

boolean

Alias
UMLS CUI [1]
C0178601
discontinuation from pervious therapy with a dopamine agonist after an adequate length of treatment, at adequate dose, due to lack of efficacy
Beschrijving

Dopamine Agonists Discontinued | Etiology Lack of Efficacy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0178601
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0235828
any medical or psychiatric condition that jeopardizes / compromises patient's ability for participation
Beschrijving

Medical condition At risk Study Subject Participation Status | Mental condition At risk Study Subject Participation Status | Medical condition Impairing Study Subject Participation Status | Mental condition Impairing Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0221099
UMLS CUI [3,3]
C2348568
UMLS CUI [4,1]
C3840291
UMLS CUI [4,2]
C0221099
UMLS CUI [4,3]
C2348568
patient has received neuroleptics, dopamine releasing substances, dopamine modulating substances, alpha-methyldopa, metoclopramide, mao-a inhibitors, budipine, or tolcapone
Beschrijving

Antipsychotic Agents | Substance Releasing Dopamine | Substance Modulating Dopamine | Methyldopa | Metoclopramide | Monoamine Oxidase Inhibitors | budipine | tolcapone

Datatype

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2,1]
C0439861
UMLS CUI [2,2]
C1283071
UMLS CUI [2,3]
C0013030
UMLS CUI [3,1]
C0439861
UMLS CUI [3,2]
C0443264
UMLS CUI [3,3]
C0013030
UMLS CUI [4]
C0025741
UMLS CUI [5]
C0025853
UMLS CUI [6]
C0026457
UMLS CUI [7]
C0054202
UMLS CUI [8]
C0246330
electroconvulsive therapy
Beschrijving

Electroconvulsive Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0013806
patient has a
Beschrijving

Patient has

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C3539897
current/anticipated psychotherapy or behavior therapy
Beschrijving

Psychotherapy | Behavior Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0033968
UMLS CUI [2]
C0004933
history of deep brain stimulation
Beschrijving

Deep Brain Stimulation

Datatype

boolean

Alias
UMLS CUI [1]
C0394162
history of suicide attempt or has suicidal ideation
Beschrijving

History of suicide attempt | Feeling suicidal

Datatype

boolean

Alias
UMLS CUI [1]
C0455507
UMLS CUI [2]
C0424000
impulse control disorder
Beschrijving

Impulse control disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0868740
severe depression
Beschrijving

Severe depression

Datatype

boolean

Alias
UMLS CUI [1]
C0588008
Terug naar het begin van de pagina

Similar models

Eligibility Idiopathic Parkinson's Disease NCT01782222

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease Early | Parkinson Disease Advanced
Item
patients with early or advanced idiopathic parkinson's disease
boolean
C0030567 (UMLS CUI [1,1])
C1279919 (UMLS CUI [1,2])
C0030567 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
Parkinson Disease Advanced | Levodopa Dose Stable U/day
Item
patients with advanced idiopathic parkinson's disease: intake of levodopa on a stable dose of at least 200 mg/day
boolean
C0030567 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0023570 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0456683 (UMLS CUI [2,4])
Control Unsatisfactory Parkinson Disease | Motor symptoms Treating
Item
unsatisfactory control of parkinson's disease motor symptoms under current treatment
boolean
C2587213 (UMLS CUI [1,1])
C0439856 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
C0426980 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
Apathy Associated with Parkinson Disease
Item
patients experiencing apathy associated with parkinson's disease
boolean
C0085632 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
Hoehn and Yahr Stage
Item
hoehn and yahr stage score of i to iv
boolean
C3639483 (UMLS CUI [1])
Mini-mental state examination
Item
mini-mental state examination score ≥ 25
boolean
C0451306 (UMLS CUI [1])
Antidepressive Agents Dose Stable
Item
if an antidepressant drug is taken, the dose must be stable
boolean
C0003289 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Dopamine Agonists
Item
therapy with a dopamine agonist
boolean
C0178601 (UMLS CUI [1])
Dopamine Agonists Discontinued | Etiology Lack of Efficacy
Item
discontinuation from pervious therapy with a dopamine agonist after an adequate length of treatment, at adequate dose, due to lack of efficacy
boolean
C0178601 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0235828 (UMLS CUI [2,2])
Medical condition At risk Study Subject Participation Status | Mental condition At risk Study Subject Participation Status | Medical condition Impairing Study Subject Participation Status | Mental condition Impairing Study Subject Participation Status
Item
any medical or psychiatric condition that jeopardizes / compromises patient's ability for participation
boolean
C3843040 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C0221099 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0221099 (UMLS CUI [4,2])
C2348568 (UMLS CUI [4,3])
Antipsychotic Agents | Substance Releasing Dopamine | Substance Modulating Dopamine | Methyldopa | Metoclopramide | Monoamine Oxidase Inhibitors | budipine | tolcapone
Item
patient has received neuroleptics, dopamine releasing substances, dopamine modulating substances, alpha-methyldopa, metoclopramide, mao-a inhibitors, budipine, or tolcapone
boolean
C0040615 (UMLS CUI [1])
C0439861 (UMLS CUI [2,1])
C1283071 (UMLS CUI [2,2])
C0013030 (UMLS CUI [2,3])
C0439861 (UMLS CUI [3,1])
C0443264 (UMLS CUI [3,2])
C0013030 (UMLS CUI [3,3])
C0025741 (UMLS CUI [4])
C0025853 (UMLS CUI [5])
C0026457 (UMLS CUI [6])
C0054202 (UMLS CUI [7])
C0246330 (UMLS CUI [8])
Electroconvulsive Therapy
Item
electroconvulsive therapy
boolean
C0013806 (UMLS CUI [1])
Patient has
Item
patient has a
boolean
C0030705 (UMLS CUI [1,1])
C3539897 (UMLS CUI [1,2])
Psychotherapy | Behavior Therapy
Item
current/anticipated psychotherapy or behavior therapy
boolean
C0033968 (UMLS CUI [1])
C0004933 (UMLS CUI [2])
Deep Brain Stimulation
Item
history of deep brain stimulation
boolean
C0394162 (UMLS CUI [1])
History of suicide attempt | Feeling suicidal
Item
history of suicide attempt or has suicidal ideation
boolean
C0455507 (UMLS CUI [1])
C0424000 (UMLS CUI [2])
Impulse control disorder
Item
impulse control disorder
boolean
C0868740 (UMLS CUI [1])
Severe depression
Item
severe depression
boolean
C0588008 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial